Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mei Cao

Showing results (471-480 of 486) with videos related to

Pageof 49
Sort By:
Journal of Medical Virology|November 16, 2023
The interaction and mediation effects between the host genetic factors and Epstein-Barr virus VCA-IgA in the risk of nasopharyngeal carcinomaHua Diao, Wen-Qiong Xue, Tong-Min Wang, et al.
Cell Genomics|February 15, 2024
Host genetic variants, Epstein-Barr virus subtypes, and the risk of nasopharyngeal carcinoma: Assessment of interaction and mediationMiao Xu, Ruimei Feng, Zhonghua Liu, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|October 6, 2009
Induction-concurrent chemoradiotherapy versus induction chemotherapy and radiotherapy for locoregionally advanced nasopharyngeal carcinomaPei-Yu Huang, Hai-Qiang Mai, Dong-Hua Luo, et al.
The Lancet. Digital Health|September 27, 2024
Highly sensitive detection platform-based diagnosis of oesophageal squamous cell carcinoma in China: a multicentre, case-control, diagnostic studyYu Wang, Shan Xing, Yi-Wei Xu, et al.
American Journal of Epidemiology|December 21, 2012
Two Epstein-Barr virus-related serologic antibody tests in nasopharyngeal carcinoma screening: results from the initial phase of a cluster randomized controlled trial in Southern ChinaZhiwei Liu, Ming-Fang Ji, Qi-Hong Huang, et al.
Life Medicine|January 28, 2025
A biomarker framework for cardiac aging: the Aging Biomarker Consortium consensus statement, Weiwei Zhang, Yang Che, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2024
Impact of an Epstein-Barr Virus Serology-Based Screening Program on Nasopharyngeal Carcinoma Mortality: A Cluster-Randomized Controlled TrialWen-Jie Chen, Xia Yu, Yu-Qiang Lu, et al.
Journal of Extracellular Vesicles|March 4, 2026
An Extracellular Vesicle Protein-Based Machine Learning Framework for Early Detection of Oesophageal Squamous Cell Carcinoma: A Multicentre, Prospective StudyYu Wang, Shan Xing, Ya-Xian Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2018
Induction Chemotherapy plus Concurrent Chemoradiotherapy in Endemic Nasopharyngeal Carcinoma: Individual Patient Data Pooled Analysis of Four Randomized TrialsYu-Pei Chen, Ling-Long Tang, Qi Yang, et al.
Nature Genetics|June 19, 2019
Genome sequencing analysis identifies Epstein-Barr virus subtypes associated with high risk of nasopharyngeal carcinomaMiao Xu, Youyuan Yao, Hui Chen, et al.
Pageof 49

Showing results (471-480 of 486) with videos related to

Sort By:
Pageof 49
Journal of Medical Virology|November 16, 2023
The interaction and mediation effects between the host genetic factors and Epstein-Barr virus VCA-IgA in the risk of nasopharyngeal carcinomaHua Diao, Wen-Qiong Xue, Tong-Min Wang, et al.
Cell Genomics|February 15, 2024
Host genetic variants, Epstein-Barr virus subtypes, and the risk of nasopharyngeal carcinoma: Assessment of interaction and mediationMiao Xu, Ruimei Feng, Zhonghua Liu, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|October 6, 2009
Induction-concurrent chemoradiotherapy versus induction chemotherapy and radiotherapy for locoregionally advanced nasopharyngeal carcinomaPei-Yu Huang, Hai-Qiang Mai, Dong-Hua Luo, et al.
The Lancet. Digital Health|September 27, 2024
Highly sensitive detection platform-based diagnosis of oesophageal squamous cell carcinoma in China: a multicentre, case-control, diagnostic studyYu Wang, Shan Xing, Yi-Wei Xu, et al.
American Journal of Epidemiology|December 21, 2012
Two Epstein-Barr virus-related serologic antibody tests in nasopharyngeal carcinoma screening: results from the initial phase of a cluster randomized controlled trial in Southern ChinaZhiwei Liu, Ming-Fang Ji, Qi-Hong Huang, et al.
Life Medicine|January 28, 2025
A biomarker framework for cardiac aging: the Aging Biomarker Consortium consensus statement, Weiwei Zhang, Yang Che, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2024
Impact of an Epstein-Barr Virus Serology-Based Screening Program on Nasopharyngeal Carcinoma Mortality: A Cluster-Randomized Controlled TrialWen-Jie Chen, Xia Yu, Yu-Qiang Lu, et al.
Journal of Extracellular Vesicles|March 4, 2026
An Extracellular Vesicle Protein-Based Machine Learning Framework for Early Detection of Oesophageal Squamous Cell Carcinoma: A Multicentre, Prospective StudyYu Wang, Shan Xing, Ya-Xian Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2018
Induction Chemotherapy plus Concurrent Chemoradiotherapy in Endemic Nasopharyngeal Carcinoma: Individual Patient Data Pooled Analysis of Four Randomized TrialsYu-Pei Chen, Ling-Long Tang, Qi Yang, et al.
Nature Genetics|June 19, 2019
Genome sequencing analysis identifies Epstein-Barr virus subtypes associated with high risk of nasopharyngeal carcinomaMiao Xu, Youyuan Yao, Hui Chen, et al.
Pageof 49